PharmaHub · Other Pharma & Biotech · Asia Pacific

Ayush And Alternative Medicine Industry In India Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The AYUSH and Alternative Medicine industry in India encompasses Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa Rigpa, and Homeopathy, with a market valued at approximately $14.5 billion in 2025 and expanding at a compound annual growth rate of 14.1%. As one of the world's oldest medical traditions rooted in centuries of documented practice, the sector has gained substantial momentum from rising consumer preference for natural and holistic wellness solutions. Government-led institutional support, including a dedicated Ministry of Ayush, alongside a flourishing wellness tourism economy and growing global demand for herbal and traditional remedies, are the primary catalysts propelling this growth trajectory.

Market size · 2025
$14.5 billion
CAGR · 2025–2030
14.1%
Forecast · 2030
$28 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $14.5bn2030 est: $28bn
Read the full Ayush And Alternative Medicine Industry In India report →

Market Overview

India's AYUSH and Alternative Medicine market represents one of the most dynamic segments within the country's broader healthcare ecosystem, combining traditional healing systems with contemporary natural wellness products. Valued at approximately $14.5 billion in 2025, the market reflects a robust upward trajectory driven by deep-rooted cultural heritage and increasing mainstream acceptance of alternative treatment modalities. The sector benefits from formal governmental recognition, with a dedicated Ministry of Ayush overseeing the development, standardization, and promotion of traditional medicine practices across the nation.

  • The market integrates six recognized traditional systems: Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa Rigpa, and Homeopathy
  • Official government data through the Press Information Bureau tracks wellness and medical tourism as key economic contributors linked to the sector
  • The industry has grown approximately 15-fold over the decade spanning 2015 to 2025, reflecting rapid commercialization of traditional medicine

Growth Drivers

A confluence of factors is accelerating market expansion, including heightened consumer awareness of preventive healthcare and a global shift toward plant-based and natural therapeutics. The wellness tourism industry plays a particularly significant role, positioning India as a premier destination for medical and holistic wellness retreats that leverage the country's traditional medicine expertise. Additionally, India's dominance within the Asia-Pacific Ayurveda segment, commanding approximately 78.6% of regional revenue, underscores its structural advantage in both domestic consumption and export potential.

  • Rising prevalence of chronic lifestyle diseases has increased demand for long-term, natural wellness solutions over synthetic alternatives
  • Wellness and medical tourism inflows benefit from India's established reputation in Ayurvedic treatments and yoga-based therapies
  • Increasing global demand for herbal supplements and traditional remedies supports export-oriented growth for Indian manufacturers
Want a deeper cut on Ayush And Alternative Medicine Industry In India? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

Ayurveda stands as the dominant segment within the broader market, with the Asia-Pacific region, led by India, accounting for the majority of global Ayurveda market revenue. The herbal remedies and dietary supplements category represents another high-growth subsector, appealing to both domestic consumers and international markets seeking natural alternatives. Regional concentration remains heavily centered on southern and western Indian states with deep Ayurvedic traditions, though urban centers nationwide are experiencing rapid expansion of modern retail and e-commerce distribution channels for AYUSH products.

  • The Asia-Pacific region, dominated by India, holds approximately 78.6% of the global Ayurveda market, underscoring India's commanding regional position
  • Herbal remedies and dietary supplements are emerging as high-velocity segments within the alternative medicine product category
  • South and western Indian states maintain traditional concentration, while tier-1 and tier-2 urban centers are driving modern retail adoption

Trends and Outlook

What are the recent trends and outlook?

The market is positioned for sustained expansion, with the sector projected to continue its upward climb toward significantly larger valuations in the coming years, supported by deepening digital penetration and increasing clinical validation of traditional therapies. E-commerce platforms and modern trade channels are reshaping how AYUSH products reach consumers, particularly younger demographics open to preventive and holistic wellness approaches. As global interest in integrative medicine grows, Indian AYUSH companies are increasingly positioned to capture international market share through product innovation, regulatory compliance, and strategic partnerships.

  • Digital commerce and direct-to-consumer platforms are expanding access to AYUSH products across both urban and rural markets
  • Clinical research and evidence-based positioning are becoming critical for traditional medicine brands seeking regulatory and consumer credibility
  • International export opportunities are expanding as global markets increasingly recognize India's leadership in natural and traditional medicine
Talk to a Claight analyst
Do you want to research Ayush And Alternative Medicine Industry In India?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.